Carpenter Technology Corporation CRS
Composite 61/100; the shares have moved about 47% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 18/100 — a strong mark against it.
Balance-sheet strength ranks 85/100 — a strong point in its favour. Growth ranks 75/100 — a strong point in its favour. Quality ranks 73/100 — a moderate point in its favour.
Valuation ranks 18/100 — a strong mark against it. Income ranks 35/100 — a moderate mark against it.
What the company does Carpenter Technology (CRS) produces specialty metals—titanium, stainless steels, tool steels, and powder metals—serving aerospace, defense, medical, energy, and industrial markets. Its two segments, Specialty Alloys Operations and Performance Engineered Products, supply high-performance materials globally.
Key financials CRS shows strong profitability: ROE 25%, ROA 11%, ROCE 20%, with gross/operating/net margins at 30%/23%/16%. Revenue grew 12% and EPS 47% year-over-year. Debt/equity is 0.34 and interest coverage 13.4x, supporting financial flexibility.
Stock health Momentum is robust: +24% over 3 months, +52% over 6 months, and +83% over 12 months, though down 20% from its 52-week high. Sideravia scores it Strong Quality (68th percentile) with high Growth (76th) and Strength (84th), but Valuation is in the 17th percentile.
Price vs fair value CRS trades at a PREMIUM of 36% to our fair-value estimate of 323.38 and at a discount of 13% to the analyst 12-month target of 571.33. - Q4 earnings and revenues surpassed estimates, highlighting record operating income (GuruFocus.com, Zacks) - Earnings call emphasized strong growth outlook and positive momentum (Zacks, MarketBeat) - Forward P/E of 23.36 contrasts with trailing P/E of 63.68, signaling rich near-term valuation (Valuation data)
Looking forward Analysts expect continued strength, with a 12-month target implying 13% upside from the current price. Forward PEG of 0.14 suggests potential undervaluation relative to growth, though high trailing multiples temper enthusiasm.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.